Portfolio5 March 2025
Epoch Biodesign just closed an oversubscribed $18.3M Series A
Epoch Biodesign just closed an oversubscribed $18.3M Series A to scale its breakthrough enzymatic recycling technology.
Don't invest unless you're prepared to lose all the money you invest. Read More
Epoch Biodesign just closed an oversubscribed $18.3M Series A to scale its breakthrough enzymatic recycling technology.
Epoch Biodesign just closed an oversubscribed $18.3M Series A to scale its breakthrough enzymatic recycling technology—turning plastic waste into new materials.
We backed Epoch in 2021, and it’s incredible to see their progress in tackling one of the world's biggest environmental challenges.
Check out the TechCrunch article for more info - https://lnkd.in/e9x5tbmS
Congrats to Jacob Nathan and team 🎉
[video width="1286" height="1608" mp4="https://www.ascension.vc/wp-content/uploads/2025/03/EPOCH-VIDEO-030325_.mp4"][/video]